Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

HHS Announces Forum on Pharmaceutical Innovation, Access, Affordability and Better Health

HHS Logo blueWashington, DC, November 16, 2015 ― The U.S. Department of Health and Human Services yesterday announced a public forum to explore pharmaceutical innovation, access, affordability and better health.

Below is the text of the invitation:

Modern medicine, including new pharmaceuticals that cure or help combat life threatening diseases, continues to deliver significant benefits for patients.  And in general, the development of new, innovative medicines has been good for both patients and our economy.

However, the high and growing cost of drugs has created hardship for families, employers, and states. Specialty medications represent only 1% of all prescriptions but, in 2014, these medications resulted in over 31% of all drug spending.

Secretary Burwell is asking stakeholders to share information as to how to address this complex problem.

The forum will bring together consumers, providers, employers, manufacturers, health insurance issuers, representatives from state and federal government, and other stakeholders to share information and discuss ideas to increase access to information, drive innovation, strengthen incentives and promote competition.

We seek your views on how to foster a health care system that leads in innovation, delivers the most affordable, highest quality medicines and results in healthier people.

During the forum, we will hear from a broad range of stakeholders on opportunities to improve patient access to affordable prescription drugs, develop innovative purchasing strategies and incorporate value-based and outcomes-based models into purchasing programs in both the public and private sectors.

We acknowledge this is a multi-faceted problem with no one solution, but there is a significant benefit – to all of us – of working together to find a solution.

The forum will take place at HHS in Washington, D.C. on November 20 and will be live webcast.

For additional information, click here.